Supplemental information from YAP1 and COX2 Coordinately Regulate Urothelial Cancer Stem-like Cells

Authors:
  • AOAkira Ooki
    Akira Ooki
  • MPMaria Del Carmen Rodriguez Pena
    Maria Del Carmen Rodriguez Pena
  • LMLuigi Marchionni
    Luigi Marchionni
  • WDWikum Dinalankara
    Wikum Dinalankara
  • ABAsma Begum
    Asma Begum
  • NHNoah M. Hahn
    Noah M. Hahn
  • CVChristopher J. VandenBussche
    Christopher J. VandenBussche
  • ZRZeshaan A. Rasheed
    Zeshaan A. Rasheed
  • SMShifeng Mao
    Shifeng Mao
  • GNGeorge J. Netto
    George J. Netto
  • DSDavid Sidransky
    David Sidransky
  • MHMohammad O. Hoque
    Mohammad O. Hoque

Abstract
Supplemental information includes Supplemental Figure S1. The characterization of SOX2 as an oncogene in bladder cancer, Supplemental Figure S2. Stem cell-related molecules associated with SOX2 expression, Supplemental Figure S3. CD24+/CD133+ as a potential marker for SOX2-expressing CSCs, Supplemental Figure S4. COX2/PGE2 signaling pathway in regulating SOX2, Supplemental Figure S5. The association of PGE2 expression with apoptosis in YAP1-LV or YAP1-sh cells, Supplemental Figure S6. Correlation among SOX2, YAP1, and COX2 expression in human UCB samples, Supplemental Figure S7. CSC expansion following CDDP treatment suppressed by combination treatment with verteporfin and celecoxib, Supplemental Figure S8. The EGFR-regulated YAP1 expression via PI3K signaling in basal-type UCB, and Supplementary Materials and Methods.